Try our beta test site

A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal Disease

This study has been terminated.
(Voluntary halt of further dosing due to an FDA Clinical Hold issued in relation to Dynavax study DV2-HBV-10)
Information provided by (Responsible Party):
Dynavax Technologies Corporation Identifier:
First received: July 5, 2007
Last updated: November 8, 2016
Last verified: November 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 16, 2014